News and Announcements

Home > About Us > News > News And Announcements


23-Oct-2016 (Sun) article archive:   

A first “made in Singapore” anti-diabetic drug, DAA-I, has successfully completed its Stage I clinical trial and is the result of 20 years of extensive research resulting from a joint collaboration between NUS Yong Loo Lin School of Medicine, Singapore Clinical Research Institute and the National University Health System. The new treatment affects our bodies' production of insulin to help delay the worsening of the disease. The research team is calling for participants for the first stage of trials to prepare for its release into the market in the next 3-5 years.


Click here to view article in Lianhe Zaobao